# BREADS: Breast Adjuvant Diet Study

> **NCT04189263** · PHASE2 · TERMINATED · sponsor: **Farin Amersi** · enrollment: 6 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** Carbohydrate restricted dietary intervention
- **DRUG:** standard of care aromatase inhibitors

## Key facts

- **NCT ID:** NCT04189263
- **Lead sponsor:** Farin Amersi
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-02-04
- **Primary completion:** 2023-03-30
- **Final completion:** 2023-03-30
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Low participant compliance, slow recruitment
- **Last updated:** 2023-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04189263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04189263, "BREADS: Breast Adjuvant Diet Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04189263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*